日本数位医疗市场 - 2025-2033

2024 年日本数位健康市场规模达到 109.6 亿美元，预计到 2033 年将达到 5,142 万美元，2025-2033 年预测期内的复合年增长率为 19.0%。

数位健康是指利用数位科技改善医疗服务、增强健康效果并促进病患的整体健康。这个快速发展的领域将行动应用程式、穿戴式装置、人工智慧 (AI)、远距医疗和电子健康记录 (EHR) 等技术融入医疗保健的各个方面。目标是提高护理的效率、可及性和质量，使医疗服务更加个人化、及时性和有效。

数位健康解决方案有助于更好地协调各个医疗保健提供者之间的护理，改善患者体验并减少分散的护理。随着科技的不断发展，数位医疗可望进一步彻底改变医疗保健的提供方式，提供更便利、更有效率、以病人为中心的服务。

市场动态：

驱动因素与约束因素

老年人口不断增加

日本人口老化是数位健康市场的主要驱动力，因为慢性病发病率较高以及长期照护的需求导致对医疗保健服务的需求增加。远距医疗、远端监控、穿戴式装置和人工智慧工具等数位健康解决方案对于应对这些挑战至关重要，因为它们使老年人能够远端获得护理、即时追踪重要健康指标并更有效地管理慢性病。

这些技术不仅提供个人化的护理，而且还减轻了医疗保健提供者的负担，特别是在专业人员短缺的农村地区。此外，辅助机器人和智慧家居解决方案等创新正在改善老年人的日常生活。在政府透过「医疗政策2025」等措施的支持下，数位健康解决方案越来越多地融入日本的医疗保健体系，确保老年人能够得到所需的护理，同时提高整体医疗保健的效率和可及性。

技术限制

预计技术限制将在多个方面严重阻碍日本数位健康市场的成长。儘管日本拥有强大的技术基础设施，但医疗保健系统之间互通性不足、软体过时以及缺乏标准化资料格式等挑战可能会限制数位健康解决方案的无缝整合。

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动态

• 影响因素
  • 驱动程式
    • 老年人口不断增加
    • 家庭医疗保健越来越多地采用先进技术
  • 限制
    • 技术限制
    • 资料隐私问题
  • 机会
    • 市场参与者的策略主动性不断增强
• 影响分析

第五章：战略洞察与产业展望

• 市场领导者和先驱者
  • 新兴先锋和杰出参与者
  • 拥有最大销售品牌的成熟领导者
  • 拥有成熟产品的市场领导者
• CXO 观点
• 最新进展与突破
• 案例研究/正在进行的研究
• 监管和报销情况
• 波特五力分析
• 供应链分析
• 专利分析
• SWOT 分析
• 未满足的需求和差距
• 市场进入和扩张的推荐策略
• 情境分析：最佳情况、基本情况和最坏情况预测
• 定价分析和价格动态
• 关键意见领袖

第 6 章：按组件

• 硬体
• 软体
• 服务

第 7 章：按类型

• 行动医疗
• 电子健康
• 远距医疗
• 健康分析
• 其他的

第 8 章：按最终用户

• 医疗保健提供者
• 医疗保健消费者
• 其他的

第九章：竞争格局

• 竞争格局
• 市场定位/份额分析
• 併购分析

第十章：公司简介

• OMRON Corporation
• 公司概况
• 产品组合
  • 产品描述
  • 产品关键绩效指标 (KPI)
  • 历史和预测产品销售量
• 财务概览
  • 公司收入
  • 地区收入份额
  • 收入预测
• 主要进展
  • 合併与收购
  • 关键产品开发活动
  • 监管部门批准等
• SWOT 分析
• CureApp
• Shionogi & Co., Ltd.
• HealthNode
• Whill
• Allm Inc.
• Dai-ichi Life Holdings, Inc.
• Xiaomi
• Hitachi Energy Ltd.
• Similar data will be provided for each market player.

第 11 章：附录

The Japan digital health market reached US$ 10.96 billion in 2024 and is expected to reach US$ 51.42 million by 2033, growing at a CAGR of 19.0% during the forecast period of 2025-2033.

Digital health refers to using digital technologies to improve healthcare delivery, enhance health outcomes, and promote a patient's overall well-being. This rapidly growing field integrates technology such as mobile apps, wearables, artificial intelligence (AI), telemedicine, and electronic health records (EHRs) into various aspects of healthcare. The objective is to enhance the efficiency, accessibility, and quality of care, making healthcare services more personalized, timely, and effective.

Digital health solutions facilitate better coordination of care across various healthcare providers, improving patient experiences and reducing fragmented care. As technology continues to evolve, digital health is expected to further revolutionize how healthcare is delivered, offering more accessible, efficient, and patient-centered services.

Market Dynamics: Drivers & Restraints

Rising Geriatric Population

Japan's aging population is a key driver of the digital health market, as the demand for healthcare services increases due to the higher prevalence of chronic diseases and the need for long-term care. Digital health solutions, such as telemedicine, remote monitoring, wearables, and AI-driven tools, are essential in addressing these challenges by enabling elderly individuals to access care remotely, track vital health metrics in real time, and manage chronic conditions more effectively.

These technologies not only provide personalized care but also reduce the burden on healthcare providers, particularly in rural areas where there is a shortage of professionals. Additionally, innovations like assistive robots and smart home solutions are improving the daily lives of elderly people. With government support through initiatives like the "Healthcare Policy 2025," digital health solutions are increasingly integrated into Japan's healthcare system, ensuring that elderly citizens can receive the care they need while improving overall healthcare efficiency and accessibility.

Technical Limitations

Technical limitations are expected to significantly hinder the growth of Japan's digital health market in several ways. Despite Japan's strong technological infrastructure, challenges such as insufficient interoperability between healthcare systems, outdated software, and lack of standardized data formats can limit the seamless integration of digital health solutions.

Segment Analysis

The Japan digital health market is segmented based on component, type, and end-user.

Type:

mHealth in the type segment is expected to dominate in the Japan digital health market.

Japan has a high smartphone penetration rate and a tech-savvy population, making mobile health applications and services highly accessible and widely adopted. The aging population, in particular, is a major driver for mHealth solutions, as mobile apps and wearables can help older adults monitor their health, track vital signs, and manage chronic conditions without requiring frequent visits to healthcare providers.

mHealth solutions, such as health tracking apps, medication reminders, and telemedicine platforms, offer convenience and flexibility for patients, empowering them to take charge of their health. Moreover, Japan's focus on preventative care and wellness aligns with the growing use of mHealth tools that promote healthier lifestyles, encourage regular physical activity, and track diet and sleep. As more healthcare providers and patients embrace mobile solutions for daily health management, the mHealth segment is expected to lead Japan's digital health market growth by offering efficient, accessible, and personalized healthcare options.

Competitive Landscape

The major players in Japan digital health market include Takeda Pharmaceutical Company Limited, OMRON Corporation, CureApp, Shionogi & Co., Ltd., HealthNode, Whill, Allm Inc., Dai-ichi Life Holdings, Inc., Xiaomi, and Hitachi Energy Ltd., among others.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials and product pipelines and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyze product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Japan Digital Health Market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Component
• 3.2. Snippet by Type
• 3.3. Snippet by End-User

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Rising Geriatric Population
    • 4.1.1.2. Increasing Adoption of Advanced Technologies in Home Healthcare
  • 4.1.2. Restraints
    • 4.1.2.1. Technical Limitations
    • 4.1.2.2. Data Privacy Concerns
  • 4.1.3. Opportunity
    • 4.1.3.1. Increasing Strategic Initiatives by Market Players
• 4.2. Impact Analysis

5. Strategic Insights and Industry Outlook

• 5.1. Market Leaders and Pioneers
  • 5.1.1. Emerging Pioneers and Prominent Players
  • 5.1.2. Established leaders with largest selling Brand
  • 5.1.3. Market leaders with established Product
• 5.2. CXO Perspectives
• 5.3. Latest Developments and Breakthroughs
• 5.4. Case Studies/Ongoing Research
• 5.5. Regulatory and Reimbursement Landscape
• 5.6. Porter's Five Forces Analysis
• 5.7. Supply Chain Analysis
• 5.8. Patent Analysis
• 5.9. SWOT Analysis
• 5.10. Unmet Needs and Gaps
• 5.11. Recommended Strategies for Market Entry and Expansion
• 5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
• 5.13. Pricing Analysis and Price Dynamics
• 5.14. Key Opinion Leaders

6. By Component

• 6.1. Introduction
  • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Component
  • 6.1.2. Market Attractiveness Index, By Component
• 6.2. Hardware*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Software
• 6.4. Services

7. By Type

• 7.1. Introduction
  • 7.1.1. Analysis and Y-o-Y Growth Analysis (%), By Type
  • 7.1.2. Market Attractiveness Index, By Type
• 7.2. mHealth*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. eHealth
• 7.4. Telehealthcare
• 7.5. Health Analytics
• 7.6. Others

8. By End-User

• 8.1. Introduction
  • 8.1.1. Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 8.1.2. Market Attractiveness Index, By End-User
• 8.2. Healthcare Providers*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Healthcare Consumers
• 8.4. Others

9. Competitive Landscape

• 9.1. Competitive Scenario
• 9.2. Market Positioning/Share Analysis
• 9.3. Mergers and Acquisitions Analysis

10. Company Profiles

Key Market Players

• 10.1. OMRON Corporation*
  • 10.1.1. Company Overview
  • 10.1.2. Product Portfolio
    • 10.1.2.1. Product Description
    • 10.1.2.2. Product Key Performance Indicators (KPIs)
    • 10.1.2.3. Historic and Forecasted Product Sales
  • 10.1.3. Financial Overview
    • 10.1.3.1. Company Revenue's
    • 10.1.3.2. Geographical Revenue Shares
    • 10.1.3.3. Revenue Forecasts
  • 10.1.4. Key Developments
    • 10.1.4.1. Mergers & Acquisitions
    • 10.1.4.2. Key Product Development Activities
    • 10.1.4.3. Regulatory Approvals, etc.
  • 10.1.5. SWOT Analysis
• 10.2. CureApp
• 10.3. Shionogi & Co., Ltd.
• 10.4. HealthNode
• 10.5. Whill
• 10.6. Allm Inc.
• 10.7. Dai-ichi Life Holdings, Inc.
• 10.8. Xiaomi
• 10.9. Hitachi Energy Ltd.
• Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

11. Appendix

• 11.1. About Us and Services
• 11.2. Contact Us